An Fab based ovine antivenom has been prepared and compared both in vi
tro and in vivo with two commercial preparations. The product was foun
d to be at least four times more effective on a weight basis. The incr
eased potency, combined with the low incidence of side-effects associa
ted with ovine Fab, should result in a safer, more effective antivenom
.